Study of autoimmune polyglandular disease genetics in Taiwan
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how common autoimmune polyglandular syndrome type II is in Taiwan and what genetic differences may be involved. It uses past hospital visit records and focuses on people who had a specific pattern of autoimmune conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have visited National Taiwan University Hospital (NTUH) sometime from 2006 to 2021
- You must have at least two of these three conditions: type 1 diabetes, primary adrenal insufficiency, or autoimmune thyroid disease
- You must be 20 years old or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study collects health information from people with diabetes to help researchers better understand and improve diabetes care in Taiwan. It involves no new treatments or procedures.
This study checks for early signs of type 1 diabetes in people with autoimmune thyroid disease. It is a screening study that may help you understand your risk for the future.
This study follows people with autoimmune hepatitis (a condition where the immune system attacks the liver) and requires key blood test results at diagnosis. It may help doctors better understand this disease and how it progresses in patients in China.
This study looks at children with autoimmune hyperthyroidism (an overactive thyroid caused by the immune system attacking the thyroid gland). Researchers want to understand this condition better in children before puberty to help improve care.
This study is looking for people with type 1 diabetes to better understand the condition and how it may be managed. You might qualify if you were diagnosed by a specialist and are insulin-dependent under certain conditions.
This study follows children who are at genetic risk for type 1 diabetes or have early immune signs (autoantibodies) but do not yet need insulin. It provides extra checkups and information to catch the disease early and help families understand their child's risk.
Hear when a new Autoimmune Polyendocrine Syndrome Type II trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.